相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States
Ang Li et al.
CANCER (2020)
The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis
Nick van Es et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Thrombosis in ALL: a risk without clear mitigation
Wendy Stock
BLOOD (2020)
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial
Jeffrey Zwicker et al.
BLOOD ADVANCES (2020)
Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic
Chris E. Holmes et al.
JCO ONCOLOGY PRACTICE (2020)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Bleeding incidence and risk factors among cancer patients treated with anticoagulation
Dana E. Angelini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma
Ang Li et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH
Tzu-Fei Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
Kristen M. Sanfilippo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysis
Ang Li et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study
Jair Bar et al.
EUROPEAN JOURNAL OF CANCER (2019)
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2019)
Arterial thromboembolic events preceding the diagnosis of cancer in older persons
Babak B. Navi et al.
BLOOD (2019)
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
Frits I. Mulder et al.
HAEMATOLOGICA (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Implementation of an electronic medical record tool for early detection of deep vein thrombosis in the ambulatory oncology setting
Girish Kunapareddy et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism
Benjamin Brenner et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
Andres J. Munoz Martin et al.
BRITISH JOURNAL OF CANCER (2018)
Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer
A. Parker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
Ingrid Pabinger et al.
LANCET HAEMATOLOGY (2018)
Simplicity versus complexity: an existential dilemma as risk tools evolve
Alok A. Khorana
LANCET HAEMATOLOGY (2018)
Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations
Dawn Swan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study
Chiara Alessandra Cella et al.
ONCOLOGIST (2017)
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study
Grigoris T. Gerotziafas et al.
ONCOLOGIST (2017)
Mechanisms and risk factors of thrombosis in cancer
Anna Falange et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Cancer-associated pathways and biomarkers of venous thrombosis
Yohei Hisada et al.
BLOOD (2017)
Predicting risk of venous thromboembolism in hospitalized cancer patients: Utility of a risk assessment tool
Rushad Patell et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia
Eduard J. Libourel et al.
BLOOD (2016)
A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality
Nicole M. Kuderer et al.
ONCOLOGIST (2016)
Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience
Marie-Anne Couturier et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Implementation and validation of a risk stratification method at The Ottawa Hospital to guide thromboprophylaxis in ambulatory cancer patients at intermediate-high risk for venous thrombosis
Daniel Ben Lustig et al.
THROMBOSIS RESEARCH (2015)
Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer
Marc Carrier et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Pattern of Frequent But Nontargeted Pharmacologic Thromboprophylaxis for Hospitalized Patients With Cancer at Academic Medical Centers: A Prospective, Cross-Sectional, Multicenter Study
Jeffrey I. Zwicker et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
Melina Verso et al.
INTERNAL AND EMERGENCY MEDICINE (2012)
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prediction of venous thromboembolism in cancer patients
Cihan Ay et al.
BLOOD (2010)
Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
Toni K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival
Grace H. Ku et al.
BLOOD (2009)
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
Giancarlo Agnelli et al.
LANCET ONCOLOGY (2009)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528 693 adults
RH White et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Malignancy, thrombosis and Trousseau: the case for an eponym
AA Khorana
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
分享论文
